Pau Celada - Concepedia

Author

Pau Celada

Institut d'Investigacions Biomèdiques de Barcelona ORCID

Also Known As

Celada, Pau, P CELADA, P Celada, P. Celada, PAU CELADA, Pau Celada, Pau Celada Pedrosa, Pau eCelada, Shapiro, D.A.

130

Publications

6.3K

Citations

H-Index

Concepts

All Affiliations

Institut d'Investigacions Biomèdiques de Barcelona Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Centro de Investigación Biomédica en Red de Salud Mental Consejo Superior de Investigaciones Científicas Lundbeck (Denmark)

About

Pau Celada is an author at Institut d'Investigacions Biomèdiques de Barcelona specializing in medicine, neuroscience, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	38	2.9K
2	Social Sciences	23	27	2.2K
3	Health Sciences	9	9	642
4	Cognitive Science	3	3	296
5	Cell Biology	1	1	152

Pau Celada

Publications

Citations

H-Index

Page 1

	Year	Citations
The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. Pau Celada, M. Victoria Puig, Mercè Amargós‐Bosch, PubMed Prefrontal CortexPsychotropic MedicationNeurotransmitterPsychopharmacologySocial Sciences	2004	492
Control of Dorsal Raphe Serotonergic Neurons by the Medial Prefrontal Cortex: Involvement of Serotonin-1A, GABA<sub>A</sub>, and Glutamate Receptors Pau Celada, M. Victoria Puig, Josep M. Casanovas, Journal of Neuroscience	2001	490
Serotonin modulation of cortical neurons and networks Pau Celada, M. Victoria Puig, Francesc Artigas SHILAP Revista de lepidopterología	2013	441
Control of Serotonergic Function in Medial Prefrontal Cortex by Serotonin-2A Receptors through a Glutamate-Dependent Mechanism Raúl Martín‐Ruiz, M. Victoria Puig, Pau Celada, Journal of Neuroscience	2001	335
Involvement of 5-HT<sub>1A</sub>Receptors in Prefrontal Cortex in the Modulation of Dopaminergic Activity: Role in Atypical Antipsychotic Action Lorenzo Díaz-Mataix, M.C. Scorza, Analı́a Bortolozzi, Journal of Neuroscience NeuropsychologyDa ReleasePrefrontal CortexPsychotropic MedicationPsychopharmacology	2005	281
The activation of 5‐HT<sub>2A</sub> receptors in prefrontal cortex enhances dopaminergic activity Analı́a Bortolozzi, Lorenzo Díaz-Mataix, M.C. Scorza, Journal of Neurochemistry Da ReleasePsychotropic MedicationSynaptic TransmissionNeurotransmitterPsychopharmacology	2005	216
Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine Lucila Kargieman, Noemí Santana, Guadalupe Mengod, Proceedings of the National Academy of Sciences	2007	169
5-HT1A Receptor Agonists Enhance Pyramidal Cell Firing in Prefrontal Cortex Through a Preferential Action on GABA Interneurons Laia Lladó-Pelfort, Noemí Santana, V. Ghisi, Cerebral Cortex Prefrontal CortexSynaptic TransmissionPsychotropic MedicationNeurotransmitterPsychopharmacology	2011	152
Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABAA receptors in vivo Carlos A. Paladini, Pau Celada, James M. Tepper Neuroscience Neurobiological MechanismNigrostriatal Dopaminergic NeuronsHealth SciencesNeuroanatomyMedicine	1999	142
Gabaergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata Pau Celada, Carlos A. Paladini, James M. Tepper Neuroscience NeurophysiologyNeuroanatomyGlobus PallidusPhysiologyMedicine	1999	133

Page 1